Lacosamide 50 mg/1 (Lacosamide TABLET, FILM COATED) 50 mg/1

Lacosamide 50 mg tablets are used to manage certain types of seizures. This anticonvulsant medication is designed to help control epileptic activity in the brain. Learn more about its uses and effects.

Strength

50 mg/1

Pack Size

6 BLISTER PACK in 1 CARTON (10135-799-86) / 10 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

Marlex Pharmaceuticals, Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lacosamide is primarily used as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy. It works by stabilizing the electrical activity in the brain, which can help reduce the frequency and severity of seizures. People often wonder, 'What is Lacosamide used for?' and the answer lies in its ability to manage epileptic conditions effectively.

Side Effects

Common effects of Lacosamide may include dizziness, headache, and nausea. Some individuals might experience fatigue or blurred vision. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

Precautions & Warnings

Lacosamide should be handled with care, especially for individuals with a history of heart conditions. It is advisable to follow the guidance of a healthcare professional regarding its use. Always store the medication in a cool, dry place away from direct sunlight.

Avoid Interactions

Lacosamide may interact with other medications, particularly those that affect the central nervous system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and certain CYP inhibitors might also influence its effectiveness.

Frequently Asked Questions

Lacosamide is used as an adjunctive treatment for partial-onset seizures in adults with epilepsy.

Lacosamide is typically taken orally, and the dosage should be determined by a healthcare professional.

Common side effects may include dizziness, headache, and nausea.

Lacosamide may interact with other medications, so it's important to consult a healthcare provider before combining it with other drugs.

Lacosamide should be used with caution in individuals with heart conditions and under the guidance of a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.